Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-24.55%Return on Equity
VS
Market
Sector
Industry
History
$ 2.2Close
$ 1.22 - $ 3.46 52-Week Range
Ticker Information
Ticker
SBFMCompany Name
SUNSHINE BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQSUNSHINE BIOPHARMA INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SBFM - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 25.68M | $ -6.31M | -24.55% |
| 3/31/2025 | $ 22.7M | $ -5.03M | -22.16% |
| 12/31/2024 | $ 23.5M | $ -5.13M | -21.85% |
| 9/30/2024 | $ 25.04M | $ -4.23M | -16.88% |
| 6/30/2024 | $ 23.49M | $ -3.68M | -15.66% |
| 3/31/2024 | $ 24.82M | $ -4.09M | -16.47% |
| 12/31/2023 | $ 21.21M | $ -4.51M | -21.25% |
| 9/30/2023 | $ 21.96M | $ -26.77M | -121.88% |
| 6/30/2023 | $ 23.11M | $ -27.57M | -119.32% |
| 3/31/2023 | $ 19.43M | $ -27.21M | -140.05% |
Key Performance Insights, Last 5 Years
- SUNSHINE BIOPHARMA INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, SUNSHINE BIOPHARMA INC's average ROE has been -439.61%.
- The median ROE for SUNSHINE BIOPHARMA INC during this period was -22.16%
- SUNSHINE BIOPHARMA INC reached its highest ROE over the past 5 years at -6.35%.
- The lowest ROE recorded by SUNSHINE BIOPHARMA INC in the same timeframe -5875.62%
SUNSHINE BIOPHARMA INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for SUNSHINE BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -2.78M ] / Equity [ $ -954.84K ]
(=) ROE [ 0% ] SBFM - Return on Equity, Last 5 years
-5875.62%
Minimum
Dec 31, 2021
-6.35%
Maximum
Sep 30, 2022
-439.61%
Average
-22.16%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |